Tech Company Financing Transactions
Laverock Therapeutics Funding Round
Laverock Therapeutics closed a $16.5 million Seed financing round on 9/28/2023. Backers included Calculus Capital, Eli Lilly and Company and Eos Advisory.
Transaction Overview
Company Name
Announced On
9/28/2023
Transaction Type
Venture Equity
Amount
$16,466,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to further development of its GEiGS technology and progression of its programs in regenerative medicine and immuno-oncology, with a focus on Type I Diabetes and solid tumour responsive T-cell and macrophage based immune therapies, through to in vitro and in vivo validation. A key part of this next phase will be bringing on new members of the team and expanding lab facilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Incubator Building, Stevenage Bioscience Catalyst, Gunnels
Stevenage, SG1 2FX
UK
Stevenage, SG1 2FX
UK
Phone
Undisclosed
Website
Email Address
Overview
Laverock was founded around the core Gene Editing induced Gene Silencing Platform -- a step-change in RNAi technology. We fundamentally believe it unlocks the development of next-generation therapeutics through its unique and differentiated properties. We are actively developing a pipeline of GEiGS enabled ex vivo cell therapies, as well in vivo therapeutic approaches.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Venables
Chief Financial Officer
Sandy McDougall
Chief Operating Officer
Tom Payne
Chief Scientific Officer
Vlad Seitan
Chief Technical Officer
Tim Allsopp
Browse more venture capital transactions:
Prev: 9/28/2023: Triastek venture capital transaction
Next: 9/28/2023: Kamino Retail venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs